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For both men and women in the United States (U.S.), lung cancer is the leading cause of cancer-
related deaths – more than breast, colon, and prostate cancers, combined (American Cancer 
Society [ACS], 2017).  Not accurately identifying patients at high-risk for lung cancer 
contributes to high rates of lung cancer-related deaths and late-stage diagnosis. Lung cancer 
screening (LCS) is the newest preventive cancer screening examination and has been available in 
the U.S. since 2015 (Sorrie, Cates, & Hill, 2016).  Patients who are screened and found to be 
eligible for LCS, undergo a low-dose computerized tomography (LDCT) of the chest with 90% 
less ionizing radiation compared to conventional chest computerized tomography (Radiologic 
Society of North America) [RSNA], 2018). The purpose of this screening examination is to 
decrease lung cancer mortality by identifying early-stage lung cancers by LDCT (The National 
Lung Screening Trial Research Team [NLSTRT], 2014). LDCT decreases mortality by 20% 
compared to chest radiograph (NLSTRT, 2014).  Identifying candidates for LCS within the 
electronic medical record has proven difficult across the U.S. This difficulty is generally 
attributed to the lack of accurately documented smoking history. In a recent meta-analysis of 
four large LCS locations, incomplete documentation of tobacco smoking history was identified 
as an important challenge worth addressing (Gould et al., 2017, July 6). The purpose of this 
Doctor of Nursing Practice project is: (a) to improve the smoking history intake process, (b) 
assess the knowledge, attitudes, and procedures of smoking history intake, and (c) provide an 
increased understanding of the importance of an accurate smoking history intake and LCS. 
Keywords: lung cancer screening, low-dose computerized tomography, electronic 
medical record, smoking history documentation, lung cancer, lung cancer screening trial  
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Accurate Documentation of Smoking History through a  
Clinical Workflow Improvement Project 
Background and Significance 
Statement of Problem 
For both men and women in the U.S., lung cancer is the leading cause of cancer-related 
deaths – more than breast, colon, and prostate cancers, combined (American Cancer Society 
[ACS], 2017). In 2018, the ACS expects 234,030 new cases of lung cancer nationally and 500 
new cases in North Dakota (ND) (ACS, 2018). According to the American Lung Association 
(ALA), and the National Cancer Institute (NCI) approximately 8.6 million Americans are 
considered high-risk for lung cancer (ALA, 2017; NCI, 2017). Compared to a non-smoker, those 
who smoke increase their risk of lung cancer by 15 to 30 times. Smoking is directly attributable 
to 80% of deaths from lung cancer (ACS, 2017).   
Lung cancer screening (LCS) by low-dose computerized tomography (LDCT) is the 
newest preventive cancer screening examination in the U.S. (Sorrie, Cates, & Hill, 2016).  
Patients who are screened and found to be eligible for LCS, complete a computerized 
tomography (CT) of the chest with 90% less ionizing radiation compared to conventional chest 
CT (Radiologic Society of North America [RSNA], 2018). The purpose of this screening 
examination is to decrease lung cancer mortality by identifying early-stage lung cancers by 
LDCT (National Lung Screening Trial Research Team [NLSTRT], 2014). The National Lung 
Screening Trial was the landmark study that ultimately lead to the development of LCS 
guidelines (NLSTRT, 2011). The study enrolled 53,454 individuals at high-risk for lung cancer 
at several U.S. medical centers. The patients were randomized to receive annual chest 
radiographs or LDCT, for three consecutive years. Adherence to screening was 90%. Deaths 
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from lung cancer, in the chest radiograph group, was 309 deaths per 100,000 person-years; in the 
LDCT group there was 247 deaths per 100,000 person-years. This represents a 20% mortality 
reduction when screened with LDCT compared to chest radiograph.  
The ability to identify eligible patients for LCS within the electronic medical record 
(EMR) has proved challenging. Generally, this is because much of the critical information 
necessary to accurately document a smoking history is stored as unstructured text that many 
electronic medical records (EMRs) are unable to abstract. This contributes to missed 
opportunities to identify patients at high-risk for lung cancer.  Barber et al. (2015) noted wide 
variability in “. . . data content and a high level of missing data” which has led to necessary 
improvements in EMR efficiencies (p. e570).  The authors found that by utilizing a standardized 
smoking intake tool during vital sign evaluation, it led to a statistically significant increase in 
documented smoking history from 18.4% to 73.2% (p < .001; 95% CI 0.53 to 0.56).  This 
impacts not only how nurses complete the smoking history intake, but also improves the 
patients’ chance of being identified as a candidate for LCS. 
In a recent meta-analysis of four large LCS locations, incomplete documentation of 
tobacco smoking history was identified as an important challenge worth addressing (Gould et al., 
2017).  The authors recommended minimizing the burden of data-collection and improving 
clinical workflow; addressing specific eligibility criteria for LCS and facilitating quality 
improvement for LCS. On May 22, 2018, Davenport noted, in a recent study that was completed 
based upon Lung Cancer Screening Registry (LCSR) data of the American College of Radiology 
(ACR), that “one of the biggest obstacles for this has been the lack of an accurate smoking 
history in patients’ records;” supporting this projects purpose (p. 3). The findings of this study 
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were presented at the annual American Society of Clinical Oncology (ASCO) meeting in June of 
2018. 
Local and National Data 
According to the ACS Statistics Center, in 2018 there will be an estimated 4,110 new 
cancers in the state of North Dakota (ND) (2018). Nationally, there will be 1,735,350 new 
cancers (ACS, 2018). Table 1 summarizes the estimated new cancer rate and death rate, in ND 
and the U.S., for lung, breast, colon, and prostate cancer for 2018 (ACS, 2018). The death rates 
of lung, breast, prostate, and colorectal cancers have decreased overall since 1991, the ACS 
attributes this to reductions in smoking, early detection and treatment (ACS, 2018). In ND, that 
out of 1290 expected cancer deaths in 2018, 310 (24%) will be from lung cancer (ACS, 2018). 
Additionally, in ND, from 2006-2010, lung cancer had the highest percentage of cancer-related 
deaths for both men (27%) and women (23%) (North Dakota Cancer Coalition [NDCC], 2013).  
Table 1 










New Cancer Rate     
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     U.S.                            
Death Rate 
     ND                           





















     




The stage in which patients are diagnosed with lung cancer greatly impacts survival rates. 
According to the ACS (2018), 79% of those patients diagnosed with lung cancer were diagnosed 
at a late-stage, which greatly reduced their five-year survival rate.  From 1999-2006, individuals 
diagnosed with early-stage lung cancer had a 52.9% survival rate compared to only 3.5% for 
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late-stage diagnosis (NDCC, 2011). For that same, eight-year time-period, ND females 
diagnosed with breast cancer at early-stage had a 98% five-year survival rate, and a 23.4% late-
stage five-year survival rate (NDCC, 2011).  Improved survival rates are directly related to 
increased awareness of breast cancer and access to care, leading to improved screening to 
identify early-stage disease (World Health Organization [WHO], 2018). 
Individuals screened for breast cancer and colon cancer in ND and the U.S. is 
significantly higher than screening for lung cancer. Despite aggressive LCS program 
implementation, however, screening rates remain low. Table 2 demonstrates the screening rates 
for breast, colorectal, and lung cancer; although lung cancer screening rates are not available for 
ND. As of June 2018, a recent study found that for 2016, the national LCS rate was only 1.9% 
(Pham, Bhandari, Oechsli, Pinkston, & Kloecker, 2018). 
Table 2 





Stool Test or 
Endoscopy (>/=50) 
 LDCT   
ND 71.2% 65.3%  Not available  
National Rank 31st 37th  Not available  
U.S. 72.4% 68.9%  4%  
Note. Percentage = completed screening of those individuals eligible for screening. National Rank 1 = Highest 
value. LDCT = Low-Dose Computerized Tomography. Adapted from “Cancer Facts & Figures 2018,” by the ACS, 
2018, Retrieved from https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-
cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf 
 
Lung Cancer Screening Program 
In February of 2017, a nonprofit community hospital-based health system in the Midwest 
launched a comprehensive LCS program.  A comprehensive LCS program is a process in which 
patients that qualify for LCS meet with a healthcare provider to complete a shared decision-
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making appointment to discuss the risks and benefits of LCS and jointly decide if the patient 
should undergo LDCT. Patients are screened annually, following a shared decision-making 
appointment, if the patient remains qualified for LCS. The patient will undergo the LDCT and 
further treatment or monitoring based upon the LDCT results and monitoring guidelines.  
According to the Centers for Medicare & Medicaid Services (CMS), LCS basic 
requirements include (1) age 55-77, (2) 30 pack-per-year smoking history, and (3) if a previous 
smoker, quit within the past 15 years (2015).  Current EMR technology at the project facility 
does not accurately identify, through discrete data-capture, patients at high-risk for lung cancer.  
Thus, the argument could be made that technology needs to be modified to identify the high-risk 
patient, and trigger either a health maintenance alert, reminder for the healthcare professional 
(HCP) or provider to discuss LCS, or direct on-line portal messaging to the patient. 
Project Purpose 
The purpose of this project is to improve the accuracy of the smoking history intake 
process performed by ambulatory care healthcare professionals (HCPs) in internal medicine 
(IM), family medicine (FM), and pulmonary medicine (PM) departments, thereby improving the 
identification of candidates for LCS.  To screen individuals for lung cancer, those at high-risk for 
lung cancer need to be identified, so modifications to the EMR are necessary to provide specific 
smoking history intake information.   
This clinical workflow improvement project (CWIP) is designed to improve the process 
of smoking history intake, and increase the knowledge of smoking history intake and LCS, of the 
HCPs evaluating patients in the clinic setting.  Additionally, this project will evaluate the 
attitudes and skills of HCPs obtaining smoking history information, providing support for further 
research. 




Technological competency as caring in nursing (TCCN) (Appendix A) is a middle-range 
nursing theory by Rozzano Locsin (2001).  TCCN emphasizes the importance of patients being 
included and integrated within their own care as participants, as nurses strive to meet the needs 
of the patient.  Understanding the natural existence of technology, as it relates to caring in 
nursing, is important for HCPs to understand the downstream effects of process changes to the 
smoking history intake.  The primary purpose of this theory is to acknowledge the person as the 
focus of nursing and technology (Locsin, n.d.). The main concepts of the TCCN theory includes; 
(a) the harmonious coexistence of technology and caring in nursing, (b) how technology 
enhances nursing practice to provide quality care, (c) technology brings the patient closer to the 
nurse, and (d) the nurse and patient engage in conversation and develop a plan of care that is 
mutually satisfying. 
Definition of Terminology 
• Advanced EMR:  Includes electronic clinical information with extensive clinician 
notes, computerized provider order entry (CPOE) for medications, laboratory, 
radiology, consultations, and nursing orders, results management, and advanced 
decision support including guidelines, reminders, allergies, interactions, and dosing 
support (Charles, King, Patel & Furukawa, 2013). 
• Ambulatory HCPs:  Medical assistants (MAs), certified nursing assistants (CNAs), 
licensed practical nurses (LPNs), and registered nurses (RNs) working in ambulatory 
care IM, PM, and FM; excluding advanced practice registered nurses (APRNs), 
physician assistants (PAs), medical doctors (MDs) and doctors of osteopathy (DOs). 
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• Basic EMR:  Includes electronic clinical information with or without clinical notes, 
CPOE for medications, and basic results management (Charles, King, Patel & 
Furukawa, 2013). 
• Deaths per-person years: “A measurement of observation time per person and is often 
used as the denominator in incidence rates when, for varying periods, individuals are at 
risk of developing a disease, using a health service, or dying” (University of Manitoba 
[U of M], 2018, para 1). 
• Five-year survival rate:  The percentage of people who are alive five years after being 
diagnosed with a condition such as cancer (National Cancer Institute [NCI], n.d.). 
• LDCT: CT and computers produce multiple, cross-sectional images or pictures of the 
inside of the lungs with 90% less ionizing radiation compared to conventional chest CT 
(RSNA, 2018). 
• Lung cancer death:  Lung cancer mortality rate or death rate is the number of deaths per 
100,000 persons per year, with lung cancer as the underlying cause of death, occurring 
in a specified population.  
Mortality Rate = (Cancer Deaths / Population) × 100,000 (NCI, 2017). 
• Lung cancer screening examinations:  Low-dose computerized tomography (LDCT) 
completed to evaluate a patient for lung cancer. 
• Pack-year smoking history:  A calculation of smoking history based upon:  
Number of years smoked + number of packs per day smoked = pack-year smoking history. 
 
Literature Review 
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A comprehensive literature review was conducted using CINAHL, PubMed Central, and 
MEDLINE/PubMed.  The following Medical Subject Headings (MeSH) terms were used; lung 
cancer screening, low-dose CT, and smoking history documentation. The PubMed Central search 
resulted in 7,586 articles.  This was reduced by selecting academic journals and adding the 
Boolean phrase “lung cancer screening” resulting in 698 articles. A CINAHL search for smoking 
history documentation utilizing the Boolean term “record” resulted in nine journal articles. A 
MEDLINE/PubMed search resulted in 491 journal articles. 
Smoking History Documentation & Electronic Medical Records 
In a study by Zeliadt, et al. (2018, April), the authors studied the challenges associated 
with implementing LCS at Federally Qualified Health Centers. While challenges were identified 
throughout the process, smoking status is reportedly documented for all patient visits, but only 
59 (54%) documented a pack-history, which is an essential component of LCS. Also, only 29% 
of the documented information was considered reliable; meaning able to be used to make patient 
care decisions. Finally, only 13% of the documented patient histories indicated that the EMR 
data could be used to identify eligible candidates for LCS.  
Cole, Pflugeisen, Schwartz, and Miller (2018), in a cross-sectional study to evaluate the 
accuracy of EMR data to identify candidates for LCS, found that 30% of medical records had 
incomplete or inadequate smoking history information to appropriately identify the patient for 
LCS, Therefore, strategies were implemented to improve EMR documentation among medical 
assistants to better identify smokers and provide clinician reminders.  
Katki, Kovalchik, Berg, Cheung, and Chaturvedi (2016) estimated that nine million 
Americans may qualify for LCS.  Healthy People 2020 has identified a goal to reduce the lung 
cancer death rate by 10% (2017).  Screening high-risk individuals will improve overall mortality 
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related to lung cancer by 20%, as patients will be diagnosed with more treatable and potentially 
curable early-stage disease (NLSTRT, 2011).  To screen individuals, HCPs must be able to 
accurately identify them within the EMR. 
Jamal, Dube, Malarcher, Shaw and Engstrom (2012) for the CDC, note that Healthy 
People 2020 objectives for tobacco use includes screening for tobacco use within the ambulatory 
care setting (ACS) for individuals greater than 18 years old.  The authors additionally noted 
between 2005 and 2008, the CDC analyzed data from 96,232 individuals from 771 million 
outpatient visits and found that 483 million (62.7%) visits included tobacco screening (Jamal, 
Dube, Malarcher, Shaw and Engstrom, 2012).  An estimated 340 million (17.6%) of those visits 
included active tobacco users, and of those identified as tobacco users, only 20.9% of those 
individuals were counseled on smoking cessation.  Obtaining a complete, accurate smoking 
history remains the single most important technique in identifying LCS candidates. This fact 
continues to support the need for high-quality smoking history intake as part of routine intake 
and assessment. 
Barber et al. (2015), noted that accurate smoking intake documentation prior to the 
implementation of a smoking history tool within the EMR was 18.4%, and following 
implementation improved to 28.52% (55% increase) (p < .001; 95% CI 0.53 to 0.56) in the 
completion of smoking status.  This study is important to this DNP project because it emphasizes 
the importance of the integration of a standardized tool to assist HCPs obtain accurate 
information.   
Mader et al. (2016) evaluated the effectiveness and feasibility in combining “practice 
facilitation and academic detailing quality improvement (QI) strategies to help primary care 
practices increase breast, cervical, and colorectal cancer screening (CRC) among patients” (p. 
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533). The study evaluated 23 various-sized healthcare organizations, all of which implemented a 
combination of EMR workflows, patient education and outreach interventions, provider audits 
and feedback, and streamlining of reminder systems.  The intervention increased breast cancer 
screening rates by 13% (p = .001), and CRC screening rates increased by 5.6% (p = .001).  
Utilizing evidence-based strategies to modify workflows and policies is stated as an important 
intervention in QI success (Mader et al., 2016).  These results suggest that LCS may incur 
similar improvements in screening examinations following specific interventions. 
In a regression analysis of data from 2007-2010 of the National Ambulatory Medical 
Care Survey (NAMCS) and 17 clinical trials, Bae, Ford, and Huerta (2016), found that 
physicians using advanced EMR systems, compared to basic EMR systems, were much more 
likely to record, counsel, and document smoking status and offer support.  The authors suggest 
making EMR upgrades with integration of clinical decision-aids into the EMR.  This is important 
given that both QI projects and workflow improvement projects evolve to improve the way we 
collect patient data and provide high-quality shared-decision making. 
Healthcare Professional Impact 
In a Cochrane review of 49 randomized control trials by Rice, Hartmann-Boyce, and 
Stead (2013), the authors reviewed smoking cessation interventions delivered by nurses.  Over 
17,000 patients’ information was utilized in this analysis and the main outcome was abstinence 
from smoking six-months following the nursing intervention.  The review found quality evidence 
that nurses materially contributed to the success of patients to stop smoking. This study showed 
that critical decisions and changes need to be made with respect to the method that patient 
smoking history is not only obtained, but also acted upon with counseling and coordination of 
care.  Therefore, incorporating an intervention – along with the collection of smoking history 
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information – is necessary to provide the patient with the best possible outcome.  This DNP 
project focuses upon the HCPs that make initial contact with patients in the ACS, as they are a 
common source of information and support for patients, specifically obtaining smoking history 
information. 
Retrouvey, Patel, and Shaves (2016) found that increasing community awareness and 
positive perceptions of LCS by LDCT is an important factor in encouraging patients to seek out 
LCS.  In this study, radiology residents screened volunteers at a local health fair for risk factors 
for lung cancer, where they provided a survey to those participants regarding their knowledge 
and understanding of LCS.  All patients (100%) responded they would seek out screening and 
would recommend screening to friends and family, which supports the importance of identifying 
candidates for LCS. 
Literature Gaps or Limitations 
 Research exists studying the effectiveness of LCS but there is an appreciable gap 
between best-evidence and actual clinical practice related to LCS. Additionally, there is a lack of 
EMR research pertaining to smoking history intake and its’ relationship to LCS. This DNP 
project is designed to provide new and supporting knowledge to better understand the difficulties 
in obtaining and documenting an accurate and complete smoking history. 
Design and Methods 
Population 
The population from which the sample data were gathered was ambulatory care HCPs 
working in IM, FM, and PM in a nonprofit community hospital-based, fully-integrated health 
system in the Midwest.  To recruit participants, from the approximate 45 potential participants, 
project recruitment flyers (Appendix B) for the research project were posted in the identified 
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HCPs’ work location in non-patient areas.  Participants were made aware that participation was 
not mandatory, and that by opting out of the research project would not result in any 
repercussions.  
Study Design 
This DNP project was a quasi-experimental, one-group pretest-posttest design.  The HCP 
education intervention was completed on January 31, February 1, 2, and 8, 2018.  This CWIP 
provided education to HCPs who room patients for a clinic visit. The education interventions 
were designed (a) to improve HCPs’ depth-of-knowledge and understanding related to LCS and 
smoking history intake, and (b) to provide information to address more precisely organizational 
needs, and (c) to improve clinical workflows within the ambulatory care-setting. This CWIP 
provided education to HCPs that included the basics of lung cancer screening, the importance of 
smoking history documentation, and the identification of LCS candidates and how those factors 
impact lung cancer screening.   
Survey Tool and Demographics 
An informed consent was attached to the pre-intervention survey with the instructions for 
the participants to keep the consent for future reference (Appendix C). Basic, anonymous 
demographics were included in the pre-intervention survey only, which included (a) age range, 
(b) gender, (c) range of years-of-service, (d) educational level, (e) work location (IM, FM, or 
PM), (f) current or former smoker, and (g) employment status.  The voluntary survey included 
information regarding actual and perception of knowledge, attitudes, and procedures of smoking 
history intake and LCS. Participants had the option not to answer any question with which s/he 
was not comfortable.  The pre-intervention and post-intervention surveys are referenced as 
Appendices D and E, respectively.  To be able to compare the pre-intervention and post-
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intervention surveys, a self-assigned, unique, de-personalized identifier linked participants’ 
surveys.  Participants needed to remember and provide their self-chosen unique identifier when 
they completed the post-intervention survey; none of the participants forgot their de-personalized 
identifier. 
Setting and Organizational Analysis 
The DNP CWIP was completed at a nonprofit community hospital-based, health system 
in the Midwest.  This regional facility is licensed for 251 inpatient beds, with multiple 
ambulatory clinics, provides comprehensive healthcare services, and employs 2,907 employees 
with over 220 providers in over 40 specialties. 
Data Collection 
Healthcare professionals’ data. 
The survey instruments (pre-intervention and post-intervention) included 14-questions of 
six-levels of Likert-type choices. The survey instrument consisted of LCS knowledge questions, 
the importance of LCS, the importance of the identification of high-risk patients, and the 
necessity of capturing accurate patient data related to LCS. Additionally, the survey included two 
questions in which the purpose was to determine if respondents knew the informational data-
points that are necessary to identify lung cancer candidates and the method to calculate “pack-
year” smoking history.  The questions were answered either correctly or incorrectly. Finally, one 
question evaluated the HCPs’ perceived time spent on smoking history intake and 
documentation. This data was manually entered an excel spreadsheet prior to statistical analysis. 
 
Smoking history documentation data. 
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There were three time periods: (a) February to April 2017 (pre-intervention), which was 
compared with (b) October to December 2017 (pre-intervention) and (c) February to April 2018 
(post-intervention). Reports were created by information technology and did not include 
personal, identifiable private health information. The project leader did not access any protected 
patient information or medical records. Discrete data was obtained in an anonymous aggregated 
report for each of time periods which included: (a) current or former smoker, (b) if the patient 
quit smoking what year or age, (c) how many years did the patient smoke, (d) how many packs 
per day did the patient smoke, and (e) the calculated pack-year smoking history.  
A complete smoking history (for identifying candidates for LCS) includes: 
• Current or former smoker 
• Total number of years smoked. 
• Total number of packs-per-day smoked. 
• Calculated pack-year smoking history.  
• If a former smoker, number of years ago (or age) the patient quit smoking. 
Lung cancer screening data. 
Additional data consisted of the number of actual LCS examinations completed and the 
location of the referring provider, was obtained from the information technology department in 
an anonymous aggregated report from February to April 2017, which was compared with 
October to December 2017 and February to April 2018.   
Procedure for Implementation 
This DNP project was designed around the Institute for Healthcare Improvement’s (IHI) 
plan-do-study-act (PDSA) model for improvement (2018).  Within the PDSA cycle, this project 
(plan) was based upon the premise that HCPs lack some of the knowledge, skills, and EMR tools 
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needed to document a patient’s complete smoking history.  To conduct (do) this doctoral project, 
the HCPs educational sessions were completed along with the pre-intervention and post-
intervention surveys completion and ultimately data collection.  Collected data were then studied 
(study) for significant results to provide the opportunity to learn from the data. In summary, the 
results were summarized to determine the best use of the data and opportunity for additional 
research project (act) (IHI, 2018). Appendix F provides the PDSA timeline for this DNP project. 
Budget. 
Given that minimal costs were associated with this project, a budget evaluation or 
proposal was not necessary.  The project leader provided the costs of paper and printing.  The 
project intervention (HCP’s education) was completed during noon sessions in the conference 
rooms of the various departments. Staff was paid for their time by the organization. The 
organizations’ Institutional Review Board (IRB) required a business agreement (Appendix G) 
between the organization and project researcher, the purpose of which was to enhance risk 
management to reduce “liability risks that [may] contribute to financial losses” including (a) 
legal risk, (b) intangible risk, (c) technical risk and (d) security risk (Reavy, 2016, p. 208). 
EMR workflow modification. 
In consultation with nursing leadership and nursing informatics the project leader 
developed a new EMR workflow to more accurately document patient smoking history. After 
discussion with nursing informatics the original EMR form shown in figure 1 below remained 
the same; and currently is the first screening form the HCP completes as part of the smoking 
history intake process. The project leader reviewed the literature and necessity of smoking 
history documentation for LCS. From this information the new EMR form, as shown in figure 2, 
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was developed and added into the clinical workflow. This new EMR data collection tool was 
designed to improve the documentation of patient smoking history.  
Clinic smoking history intake procedure. 
Patients who present for ambulatory clinical encounters are asked several standard 
questions by HCPs, utilizing an EMR form, called the adult clinic intake. For all clinic areas, 
required clinic intake information includes reason for visit, allergies, medications, vital sign 
measurements, depression screening, suicide risk assessment, and smoking status. Figure 1 is an 
image of the smoking history form intake prior to the CWIP. Smoking status did not provide the 
necessary components to complete an accurate and complete smoking history. HCPs could make 
comments in blank fields to provide more information; but that type of information cannot be 
easily abstracted out of the medical record.  
 
Figure 1. EMR smoking history intake form pre-intervention1.  
Figure 2 is an image of the new, supplemental smoking history intake form which was 
created as part of this CWIP. This EMR form immediately went-live on the last day of the 
project educational sessions (intervention). During a patient’s clinic visit, the HCP completes the 
adult clinic intake. The original form in figure 1 is still the required initial question regarding 
smoking history; and if the patient is never a smoker, no further action is required. If any of the 
other fields are selected, in figure 1, the new supplemental form will automatically open; which 
is noted in figure 2.  




Figure 2. Supplemental EMR smoking history intake form post-intervention1.  
It should be noted that none of the fields in figure 2 are mandatory; a mandatory field 
would be highlighted yellow. At the project facility, all ambulatory clinic settings utilize the 
same adult clinic intake and there is no current way to only make fields mandatory for specific 
locations; the same form had to be implemented across the care system. The collection of 
smoking history information, as above, now creates patient data to abstract, to identifying 
patients at high-risk for lung cancer and potential candidates for LCS. Additionally, this 
improved documentation provides a more complete picture of the health history of the patient. 
Intervention procedure. 
The CWIP, which was intended to improve the accuracy of smoking history intake in 
ambulatory care, was implemented at the project facility.  The HCPs received notification three 
weeks prior to the project intervention with the distribution and posting of a flyer.  Ambulatory 
care HCPs were educated on the new CWIP for smoking history intake, the process, and the 
importance of an accurate smoking history intake on the identification of patients at high-risk for 
lung cancer.  The education session included a 15-minute audio-visual presentation with the 
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opportunity to ask follow-up questions.  No printed handouts were given during the presentation. 
Participants completed a voluntary pre-intervention and post-intervention survey. 
Resources. 
Resources necessary for this project included 33 HCPs to complete the pre-intervention 
and post-intervention surveys. Regarding the workflow intervention, resources include, one 
nursing informatics RN, two information technology data abstractors, two clinic nursing 
educators and the project leader.  The participants took approximately 15 minutes each to 
complete the surveys, and 30 minutes to attend the intervention.  The clinic nursing educators 
contributed approximately three hours each to facilitate and attend the educational interventions. 
The informatics RN and information technology data abstractors contributed approximately eight 
hours each assisting in the collection of anonymous data. 
Ethics and Protection of Human Subjects 
This DNP project was approved as exempt research by the University of North Dakota 
IRB on November 21, 2017, as noted as Appendix H.  The organizations’ IRB approved this 
project on December 22, 2017.  Private health information was not obtained.  The data recorded 
will be stored for a period of three years in a locked cabinet within the project leaders’ 
workplace.  Data entered within an electronic source is password protected.  This DNP project 
did not meet the human subjects’ research threshold for IRB review as this was a QI project to 
improve care process at the organization which project does not involve a test article or a Food 
and Drug Administration (FDA)-regulated product and there are no humans that are recipients of 
a test article or control. There are no risks in participating in this research beyond those 
experienced in everyday life. 
Outcomes 
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Objective:  HCPs will understand the knowledge and skills necessary to improve the 
accuracy and completeness of smoking history intake in an ambulatory care setting. 
Goal #1:  To provide HCPs the knowledge necessary, through a CWIP, to increase the 
accuracy and completeness of smoking history intake in ambulatory care. 
Outcome #1:  By April 2018, HCPs will increase by 25% their actual and perception of 
knowledge and skills necessary related to the importance of accuracy and completeness of 
smoking history intake in ambulatory care. 
Goal #2:  To provide HCPs the skills necessary, through a CWIP, to increase the 
accuracy and completeness of smoking history intake in ambulatory care. 
Outcome #2:  By April 2018, HCPs will increase by 25% the accuracy and completeness 
of smoking history intake in ambulatory care. 
Data Analysis and Interpretation 
The following descriptive statistics were analyzed:  frequencies, percentages, measures of 
central tendency, and minimum and maximum values of the demographic and survey results.  
Due to the design of this project, inferential statistical analysis included a paired-sample t-test, 
and a one-way ANOVA (Polit & Beck 2017).  Statistical analysis was completed using 
Statistical Package for the Social Sciences. 
Results 
 Demographics. 
 Thirty-three (73.3%) HCPs voluntarily participated in the CWIP, out of 45 
eligible. Most of the HCPs were age 31-40 (n=9; 9.1%) or 41-50 (n=9; 9.1%) and 32 (97%) 
identified as female. One participant did not respond to gender. Most HCPs had many years of 
service as a HCP; 21-30 years (n=8; 24.2%) or >30 years (n=8; 24.2%). Most of the HCPs had 
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an Associate’s Degree (n=16; 48.5%) and worked full-time (n=23; 69.7%). Majority of the HCPs 
worked in family medicine (n=19; 57.6%). There were four (12.1%) HCPs who were active 





Characteristic Frequency (N) Percentage 
Age 
     18-25 
     26-40 
     31-40 
     41-50 
     51-60 
     61-70 
 
Gender 
     Female 
     Male 
 
Years as HCP 
     2-5 
     6-10 
     11-15 
     16-20 
     21-30 
     >30 
 
Educational Level 
     HSD 
     GED  
     Associate’s Degree 
     Bachelor’s Degree 
     Doctoral Degree 
 
Employment Status 
     Full-time 
     Part-time 
 
Employment Location 
     Internal Medicine 
     Family Medicine 
     Pulmonary Medicine 
     Float 
     IM/FM 
 
Current Smoker 
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     No 
 
Former Smoker 
     Yes  













All thirty-three participants responded via the six-levels of Likert-type choices that 
ranged from “Strongly Disagree” (value = 1) to “Strongly Agree” (value = 6) or Likert-type 
choices that ranged from “Definitely Not Confident” (value = 1) to “Definitely Confident” (value 
= 6).  The first part of the “knowledge” portion of the survey instrument (both pre-intervention 
and post- intervention) which consisted of four statements. Table 4 is a summary with results of 
the pre-intervention and post-intervention survey questions. Paired-samples t-tests were used to 
compare the results of the intervention; because post-intervention means are subtracted from pre-
intervention means, a negative mean difference indicates an increase for a question. 
Table 4 
Pre- and Post-Intervention Survey Results: Summary 
 




T(33) Sig.  
(2-tailed) 
Knowledge: 
I have knowledge of LCS. 
 
Attitude: 
Obtaining an accurate smoking 
history on my patients is 
valuable. 
 
Data Capture: It is important for 
me to document an accurate 
smoking history, in order for the 
provider I work with, identify 
candidates for LCS.  
 
Data Capture: My patients 





























































































       
       
Note. 6-levels Likert-like choices. Each question represents a different portion of the pre- and post-intervention 
surveys. Fourteen questions total. 
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• For Question 1, “I have knowledge of lung cancer screening.” knowledge increased by 
an average of M = −1.27 points with SD = 1.0085.  The intervention was statistically 
significant, t(33) = −7.2497, p = .000, r2 = 62.17%. 
• For Question 2, “I am confident in my ability to obtain and document an accurate 
smoking history.” confidence increased by an average of M = −1.36 points with SD = 
1.0252. The intervention was statistically significant, t(33) = −7.6406, p = .000, r2 = 
64.61%. 
• For Question 3, “This in-service will enhance my understanding of accurate smoking 
history intake.” knowledge increased by an average of M = −0.73 points with SD = 
0.7191.  The intervention was statistically significant, t(33) = −5.8102, p = .000, r2 = 
51.32%. 
• For Question 4, “I plan to implement what I have learned from this in-service regarding 
the importance of accurate smoking history intake.” knowledge increased by an average 
of M = −0.54 points with SD = 0.7111.  The intervention was statistically significant, 
t(33) = −4.4063, p = .000, r2 = 37.72%. 
The next part of the survey instrument consisted of two questions, the purpose of which 
was to determine if respondents (a) knew the informational data-points that are necessary to 
identify lung cancer candidates and (b) the method to calculate “pack-year” smoking history.  
The questions were answered either correctly or incorrectly. Table 5 is a summary of the results 
for these two questions. 
 
 












% Increase z Sig. (2-tailed) 
What smoking history data points 
are necessary to gather to 
accurately identify LCS 
candidates? 
 
What smoking history information 
is necessary to obtain to calculate a 









































      
Note. Multiple choice questions. Two questions total. 
• For Question 5, “What smoking history data points are necessary to gather to accurately 
identify lung cancer screening candidates?” 18 of 32 respondents (56.3%) answered 
correctly on the pre-intervention survey, and 20 of 32 respondents (62.5%) answered 
correctly on the post-intervention survey; this 6.2% increase was not statistically 
significant.  z = −.509, p = .305, 95% CI [−.210, .270]. 
• For Question 6, “What smoking history information is necessary to obtain to calculate a 
pack-year smoking history?” 23 of 32 respondents (71.9%) answered correctly on the 
pre-intervention survey, and 25 of 32 respondents (78.1%) answered correctly on the 
post-intervention survey; this 6.2% increase was not statistically significant.  z = −.577, p 
= .282, 95% CI [−.274, .149]. 
Pre-intervention and post-intervention survey instrument questions 7, 8, and 9 asked 
about the importance of LCS, the importance of LCS in identifying high-risk patients, and HCPs 
attending LCS educational services, respectively. 
• For Question 7, “How important do you feel that lung cancer screening is?” opinions 
increased by an average of M = −0.364 points with SD = 0.5488.  The intervention was 
statistically significant, t(33) = −3.8066, p = .001, r2 = 31.19%. 
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• For Question 8, “How important is the identification of patients at high-risk for lung 
cancer for the purpose of lung cancer screening?” opinions increased by an average of 
M = −0.333 points with SD = 0.5951.  The intervention was statistically significant, 
t(33) = −3.2176, p = .003, r2 = 24.41%. 
• For Question 9, “Generally speaking, attending educational in-services regarding 
evidence-based practice is important?” opinions increased by an average of M = 
−0.364 points with SD = 0.4885.  The intervention was statistically significant, t(33) = 
−4.2762, p = .000, r2 = 36.41%. 
Pre-intervention and post-intervention survey questions 10 through 13 were concerned 
with the necessity of capturing accurate patient data with respect to LCS. 
• For Question 10, “The provider I work with (NP, PA, MD, DO) values an accurately 
documented smoking history.” opinions increased by an average of M = −0.606 points 
with SD = 1.0880.  The intervention was statistically significant, t(33) = −3.2000, p = 
.003, r2 = 24.24%. 
• For Question 11, “Obtaining an accurate smoking history on my patients is valuable.” 
opinions increased by an average of M = −0.273 points with SD = .5741.  The 
intervention was statistically significant, t(33) = −2.7292, p = .010, r2 = 18.91%. 
• For Question 12, “How I obtain and document smoking history impacts our ability to 
identify candidates for lung cancer screening.” opinions increased by an average of M 
= −0.303 points with SD = .5294.  The intervention was statistically significant, t(33) = 
−3.2880, p = .002, r2 = 25.28%. 
• For Question 13, “I believe that accurately documenting an appropriate smoking 
history, improves patients’ access to potentially life-saving cancer screening.” opinions 
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increased by an average of M = −0.331 points with SD = .5400.  The intervention was 
statistically significant, t(33) = −3.5456, p = .001, r2 = 27.93%. 
• Question 14 captured data on the time-difference between pre-intervention (n = 33) and 
post-intervention (n = 33) patient screening for accurate smoking history: “Obtaining 
an accurate smoking history takes how much time?” is noted in figure 3. 
Interval 
Pre-Intervention Post-Intervention 
Frequency Percent Frequency Percent 
8 to 10 Minutes 2 6.1 1 3.0 
4 to 5 Minutes 6 18.2 2 6.1 
2 to 3 Minutes 15 45.5 14 42.4 
< 1 Minute 10 30.3 16 48.5 
 
Figure 3. Perceived time it takes to obtain an accurate smoking history. 
For the less-than one-minute interval, the difference between percentages was 18.2%, 
but was not statistically significant; z = 1.51, p = .065, 95% CI [−.414, .050]. 
• The pre-intervention and post-intervention results of Question 15, “I am expected to 
take and document an accurate patient smoking history.” are as follows:  opinions 
increased by an average of M = −0.515 points with SD = .7953.  The intervention was 
statistically significant, t(33) = −3.7208, p = .001, r2 = 30.20%. 
• The pre-intervention and post-intervention results of Question 16, “My patients expect 
that I gather an accurate smoking history.” are as follows:  opinions increased by an 
average of M = −0.848 points with SD = 1.2278.  The intervention was statistically 
significant, t(33) = −3.9697, p = .000, r2 = 32.97%. 
• The pre-intervention and post-intervention results of Question 17, “It is important for 
me to document an accurate smoking history, in order for the provider I work with to 
identify candidates for lung cancer screening.” are as follows: opinions increased by an 
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average of M = −0.515 points with SD = .9056. The intervention was statistically 
significant, t(33) = −3.2679, p = .003, r2 = 24.99%. 
Smoking history results. 
Utilizing the three same time periods, aggregated data was gathered to assess the actual 
accuracy of collected smoking history during ambulatory clinic encounters in IM, FM, and PM, 
for patients age 55-77. This resulted in a 57,519 total clinic encounters. Table 6 is the missing, 
partial, and complete smoking history data. A missing smoking history is characterized by no 
response on any of the smoking history questions and a partial smoking history lacks one or 
more components of a complete smoking history. Currently, there is no way to know if this 
information is missing due to patients not providing the requested information, HCPs not asking 
the question, or a combination of both. A one-way ANOVA was completed to evaluate the mean 
of the variable “age” for each of the variables “time-period.” The age of the patient was 
statistically significant for different “time-periods” F(2, 57,516) =119.790, p < .005. 
Table 6 
Missing, Partial, & Complete Smoking History Documentation 
 
Time-Period Total Encounters  













February – April 2017 
Pre-Intervention 
 






































     
Note. Note. a. Missing Smoking History = Tobacco use not stated or asked - not documented; b. Locations = 
Internal Medicine, Pulmonary Medicine, Family Medicine; c. Ambulatory clinic encounters; d. ages 55-77 
 
For each time period, one-third of the patients identified as having never smoked. Table 7 
notes the frequencies and percentages of patients that were identified as former smokers and 
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those identified as a current, every day smokers. Both tables represent many patients that could 
potentially be considered candidates for LCS. The way in which the current EMR intake system 
is set up, HCPs may ask smoking status in multiple different ways. HCPs have the option of 
answering smoking-related questions in multiple areas of the EMR; leading to variability in the 
assessment of smoking status.  
The number of years smoked and the number of pack-per-day smoked provides the 
necessary information to calculate a pack-year smoking history. For the periods, pre-
intervention, February to April of 2017 and October to December of 2017, there was 41 (0.23%) 
and 36 (0.17%) clinic encounters, respectively, which included a partial smoking history (years 
smoked, packs-per-day smoked, and pack-year smoking history). There were no documented 
encounters, in which the year or age, the patient quit smoking. Post-intervention, from February 
to April of 2018, there was 189 encounters which included a complete smoking history as noted 
above. This represents one percent of all encounters (18,203) for this time period. Further 
statistics could not be calculated because no complete smoking histories were obtained from the 
pre-intervention first and second time period. 
Table 7 
Frequencies and Percentages of Former and Current Smokers 
Time Period Frequency  Percent  Total Encounters 
Each Period 
Feb-April 2017 
     Former 










     Former 













     Former 















 Since the LCS program began at the project facility in February of 2017, approximately 
250 patients have been screened for lung cancer by LDCT. Prior to the intervention and due to 
the lack of accurately documented smoking history data to abstract from the electronic medical 
record (EMR), a reasonably accurate number of patients that would have been considered 
eligible for LCS are nearly impossible to determine. A chi-square test of independence was 
conducted between “time-period” and “location” of providers who order LDCT. All expected 
cell frequencies were greater than five. There was a statistically significant association between 
“time-period” and “location” X2 (4) = 18.324, p <.001. The frequencies and percentages of 
LDCTs completed, for each time period, are noted in table 8.  
Table 8 
Frequencies and Percentages of LDCTs Completed 








Feb-April 2017 14 (28.6%) 21 (42.9%) 14 (28.6%)  
Oct-Dec 2017 2 (3.6%) 43 (76.8%) 10 (17.9%) 1 (1.8%) 
Feb-April 2018 12 (27.9%) 23 (53.5%) 8 (18.6%)  
 
The differences between the number of LDCTs completed between the provider groups 
and three time periods was statistically significant, (F = 5.283, p = .048). Table 9 is a summary 
to the volume of providers, number of LDCTs completed, and percentage of LDCTs per provider 
group. The Cramer's V revealed a strong relationship between the variable “location” and the 
variable “time-period” at V = .250, p = .001. A chi-square goodness-of-fit (GoF) was conducted 
to determine the difference between the observed frequencies and the expected frequencies of 
LDCTs completed for each practice location and each time period. The GoF chi-square found 
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that the number of LDCTs completed for each location and time period were not equal. For the 
first time-period, GoF chi-square = 2.000, which was not significant p = .368; indicating that the 
number of completed LDCTs completed was not statistically significantly different. For the 
second time-period, GoF chi-square = 51.527, which was significant p = .000; indicating that the 
number of completed LDCTs completed was statistically significantly different. For the third 
time-period, GoF chi-square = 8.418, which was significant p = .015; indicating that the number 
of completed LDCTs completed was statistically significantly different.   
Table 9 
Volume of Providers, Total Number & Percentage of LDCTs  
 
 Number Providers Number of LDCTs Percentage of 
LDCTs 
































Note. Based upon known number of providers in each practice location. A provider = advanced practice registered 
nurse (APRN), physician assistant (PA), medical doctor (MD), or doctor of osteopathy (DO) with a National 
Provider Identifier (NPI) number. LDCT = Low-Dose Computerized Tomography. Ambulatory IM, PM, FM. 
 
Validity of Results 
 The main premise of research and project validity is randomization. This project is not 
randomized so therefore lacks an element of scientific rigor associated with RCTs (Polit & Beck, 
2017). Thirty-three out of the 45 (73%) of the eligible HCPs participated in the project 
intervention and completed surveys. All of IM and PM HCPs were invited to participate; but 
only FM HCPs working within the local community of the project location were invited to 
participate. This organization has multiple rural community clinic locations that were not 
included due to the feasibility of the HCPs attending the same educational intervention and 
completing surveys. This represents selection bias which can affect the validity of the results 
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(Polit & Beck 2017). The educational intervention was performed by the project leader utilizing 
audio-visual technology, following a rehearsed presentation. There were several educational 
intervention sessions which could potentially lead to intervention bias (Polit & Beck, 2017). 
Great care was taken to follow the presentation as best as possible for each intervention. Finally, 
the survey utilized in this DNP project was created by the student with the assistance of 
university faculty. The validity and reliability of the survey tool has not been established.  
Interpretation 
Survey results.  
Overall, this CWIP demonstrated an increase in the perception of knowledge following 
the educational intervention. Fourteen of the seventeen survey questions pertaining to the 
perception knowledge of smoking history intake demonstrated a statistically significant increase. 
This supports the need to provide HCPs with the educational resources necessary to accurately 
obtain complete smoking history information. Also, when HCPs are provided with education, 
regarding the importance of accurate smoking history intake, they demonstrate an overall 
increased understanding, confidence in obtaining an accurate history, and understanding of 
importance of the value of LCS and accurate smoking history intake. Questions five “What 
smoking history data points are necessary to gather to accurately identify lung cancer screening 
candidates?” and six “What smoking history information is necessary to obtain to calculate a 
pack-year smoking history?” of the survey, did not demonstrate statistical significance; although 
both questions demonstrated an increase in the number of correct answers. The way in which 
these questions were asked may have been too complicated; requiring adjustment for use in the 
future. 
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Smoking history documentation. 
There was a significant amount of missing data; it is unknown if the missing data is 
related to the patient not responding to the questions from the HCP or whether the HCP did not 
ask the questions. There was less missing data after the educational intervention (third time-
period). For the pre-intervention first and second time-periods, there was not a complete smoking 
history obtained at any encounter. From February to April 2017 and October to December 2017 
all encounters lacked the year or age in which the patient quit smoking. This is a necessary 
component for LCS because one of the requirements to be screened with LDCT is that former 
smokers must have quit smoking within the past 15 years. After 15 years of abstinence from 
smoking, patients are no longer considered candidates for LCS. Post-intervention from February 
to April 2018 there were 189 (1%) encounters that included a complete smoking history. This is 
an improvement from 0% in the time-periods before the intervention. While there is importance 
and value in that 189 encounters compared to 0 completed of an accurate smoking history; it is 
quite evident that additional improvements to the EMR and on-going education are necessary to 
simplify and streamline the smoking history intake.  
Lung cancer screening. 
Regarding the data collection of the frequency of LDCTs and ordering provider’s 
location; the group means were statistically significant in their differences (p < .05). 
Understanding that the variation, most likely, is due to group differences (e.g. size of provider 
group, understanding of LDCT and LCS, and previous experience with LDCT and LCS). 
Additionally, variations in the volume of LDCTs completed, increased during the pre-
intervention time period of October to December 2017 and this could be due to patients 
including the LDCT at the end of the insurance year once their deductible was met. The opposite 
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may be true, as the volume decreased quite significantly from February to April of 2018, when 
co-pays for insurance would be at the highest. This time-period reduction could also be 
explained by decreasing enthusiasm with the LDCT LCS program. The newness had worn off by 
that time, and providers may not have been thinking about LCS as regularly. As noted in Table 8 
above the number of providers within each specific specialty and the total number of LDCTs for 
that specialty. Despite having the least number of providers, IM averaged seven LDCTs per 
provider, PM averaged eight LDCTs per provider, while FM averaged 2.8 LDCTs per provider. 
This further emphasizes where continuing education needs to be focused. 
Project Outcomes 
This CWIP met a majority of the projects’ outcomes goals. HCPs increased by at least 
25% (25.28% - 64.61%) for 11 of 14 questions their perception of knowledge and skills necessary 
related to the importance of accuracy and completeness of smoking history intake in ambulatory 
care. Three questions achieved statistical significance but not a 25% improvement (24.24%, 
24.41%, and 24.99%) in the perception of knowledge. HCPs partially met this goal, as the actual 
knowledge of the skills necessary to accurately and completely obtain a smoking history, as 
correct answers to these two questions improved by 6.2%, but was not statistically significant. 
Comparing both pre-intervention time periods to the post-intervention time period; HCPs 
increased accuracy and completeness of smoking history by at least 25%, as noted below. 
• February to April 2017: No complete smoking histories 
• October to December 2017: No complete smoking histories 
• February to April 2018: 189 complete smoking histories 
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Strengths and Limitations 
Strengths 
Strengths of this CWIP demonstrates results are likely more genuine due to the natural 
testing environment and provides results to reinforce further study and analysis. The design of 
this CWIP removes the concern of assignment bias. Ultimately this QI project is designed to 
improve HCPs’ processes which directly affect clinical patient and health outcomes. The data 
analysis of this project assists in the identification of strengths and weaknesses of current 
processes within the organization. With complete and accurate smoking history information, 
improved patient outcomes are expected by identifying individuals at high-risk for lung cancer 
and promoting LCS. This CWIP improves the organizations’ ability to correctly identify 
candidates for LCS and to ensure insurance payment of the LDCT and the organizations’ ability 
to correctly report to the Lung CT Screening Reporting & Data System, through the ACR, as 
mandated by CMS (CMS, 2015). Finally, this CWIP provides an enhanced EMR data collection 
tool for HCPs across the health system. 
Limitations 
There are limitations of this CWIP as participants of this project may have prior, personal 
experience with the subject matter and may have experienced a similar subject matter encounter 
during the time they participated in the project. Generalizability is limited due to the small, 
convenience sample of HCPs and providers although there is a significantly large number of 
clinical encounters. The pre-intervention and post-intervention surveys have not been subjected 
to reliability and internal validity testing or pilot testing. QI projects are largely based upon 
experiential learning, local context, and therefore lack of identifiable generalizable truths (Chao, 
2007). Additionally, casual inference is limited due to lack of random assignment (Polit & Beck, 
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2017). The two-actual knowledge-based questions potentially could be re-written. Improving the 
quality of these questions may make for better understood questions. Due to the large volume of 
missing completely at random data of smoking history information, the data-set likely 
underestimates the number of patients whom would be considered candidates for LCS. 
Suggestions for Improvement 
Suggestions for improvement include: (a) additional EMR modifications to minimize and 
simplify the questions asked in the adult clinic intake for smoking history, (b) provide printed 
education for HCPs to keep after the educational intervention, and (c) provide a link to 
educational resources related to smoking history intake and LCS within the organizations’ 
intranet for on-going education. 
Implications and Future Directions 
 This DNP project has provided useful information for further development of additional 
QI initiatives for LCS. From this project, recommendations for practice will assist providers and 
organizational stakeholders to make informed decisions about further project development. 
Initial efforts will be directed towards the improvement and accuracy of documentation of a 
complete smoking history intake for all adults across the entire health system. This project 
demonstrates that the consistent intake of basic smoking status is lacking, thereby making it 
difficult to obtain a complete history. This project demonstrates a significant improvement in the 
collection of smoking history information following education and with on-going education, 








As further modifications are made, focusing on simplification and standardization of 
smoking history documentation is necessary. Development of a health maintenance reminder or 
alert system, to identify potential candidates for LCS will commence, once an improved 
complete smoking history process is finalized. The development of nurse-driven preventive 
screening protocols for LCS may provide an excellent opportunity to maximize the identification 
of patients that may quality for LCS. Overall disease management and preventive screening 
guidance may benefit from further database development to better identify at-risk individuals. To 
improve the collection of accurate smoking history information, mandatory fields could be 
utilized to maximize the benefits of smoking history intake. Considering that all adult patients 
should have their smoking status asked and documented within the EMR, having such large 
numbers of missing or incomplete smoking history demonstrates an on-going challenge to be 
addressed.  
With complete and accurate smoking history information, improved patient outcomes are 
expected by identifying individuals at high-risk for lung cancer and promoting LCS. This CWIP 
improves the organizations’ ability to correctly identify candidates for LCS and to ensure 
insurance payment of the LDCT and the organizations’ ability to correctly report to the Lung CT 
Screening Reporting & Data System, through the ACR, as mandated by CMS (2015). Finally, 
this CWIP provides an enhanced EMR data collection tool for HCPs across the health system. 
EMR Inaccuracies 
Inaccuracies within EMR intake is an important concept to discuss. The HCP responsible 
for documenting within the EMR is obligated to document accurate information. Omission or 
commission of accurate medical history may lead to improper medical advice; which may 
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ultimately lead to errors, adverse outcomes, or legal activity (Veteran’s Administration, [VA], 
n.d.). Therefore, improving the overall assessment of smoking history will be important 
component of organizational initiatives and educational programming.  
Sustainability 
This project has provided useful insight to better understand which direction efforts need 
to be focused on to improve smoking history intake and increase the knowledge of HCPs 
pertaining to smoking history intake and LCS.  Upon completion of this DNP project, valuable 
and important information will provide the project leader and organization with local data to 
further improve the identification process for patients at high-risk for lung cancer and possibly 
other conditions. Not only will an accurate smoking history intake impact how patients are 
identified for LCS but for further population- health data abstraction and disease process 
management. Utilizing the feasibility, appropriateness, meaningfulness, and effectiveness 
(FAME) tool, further development of organizational guidelines for practice recommendations 
may be utilized (Reavy, 2016).  
HCPs involved in direct patient care and collection of smoking history information will 
need on-going education and access to on-line organizational resources for the accurate and 
complete collection of a smoking history. Recommendations will be intended to provide the best 
evidence-based guidelines for accurate smoking history intake and LCS. These guidelines will be 
placed within the electronic nursing policy and procedure manual. As part of the development of 
organizational guidelines for smoking history intake, providing HCPs with the knowledge and 
training necessary to provide counseling and care recommendations for active smokers is 
necessary.   
 




Overall, this project demonstrated statistically significant improvements in the perception 
of knowledge of LCS and smoking history intake. How these improvements translate into 
improved accuracy and complete documentation of smoking history and its’ impact on the 
identification of LCS candidates and LCS rates is unknown. Ensuring that HCPs have the 
knowledge and understanding to utilize current EMR technology to improve the efficiency and 
accuracy of existing smoking history intake is necessary. Obtaining a complete, accurate 
smoking history remains the single most important technique in identifying LCS candidates. 
Further study is needed to fully understand the effects of human factors in the overall accuracy 
and completeness of smoking history documentation and its’ relationship to LCS workflow for 
the successful enhancement of the EMR and LCS programs. 
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Technological Competency as Caring in Nursing: Middle-Range Nursing Theory 
By Rozzano C. Locsin, PhD, RN, FAAN (Locsin, 2001). 
 
 
Adapted conceptual model of Technological Competency as Caring in Nursing MRNT. Adapted 

























MAs, CNAs, LPNs, & RNs 
 
In ambulatory care: Internal Medicine, Family Medicine & Pulmonary Medicine. 
 
Prior to a Clinical Workflow Improvement Project you will be asked to participate in a research 
study. You will complete a survey before and after the implementation. 
 
You are NOT required to participate and choosing to not participate will have no impact on your 
employment. 
 
Title:  Accurate Documentation of Smoking History through a Clinical Workflow 
Improvement Project 
 
Purpose:  To improve the smoking history intake process to accurately identify candidates 
for lung cancer screening. 
 
Protocol:  The investigator will develop and implement a clinical workflow improvement 
project designed to better identify patients at high-risk for lung cancer. MAs, 
CNAs, LPNs, & RNs will be educated on the new smoking history intake process 
and the importance of identifying patients at high-risk for lung cancer. The 
voluntary pre-intervention and post-intervention surveys will study the 
knowledge, attitudes, and procedures of smoking history intake and lung cancer 
screening. 
 
1. Develop clinical workflow  
2. Educate staff on smoking history intake and lung cancer screening 
3. Pre-intervention survey 
4. Implement clinical workflow improvement 
5. Post-intervention survey 
 
Thank you very much for the assistance in my doctoral project. There will be no financial 
compensation. 
 
For questions or concerns please contact the principal investigator: 
Heidi Bender, MS, APRN, FNP-C, Doctor of Nursing Practice-Student 
857-5741 (office); heidi.bender@ndus.edu; heidi.bender@trinityhealth.org 
OR 
Dr. Mary Jane Rivard, DNP, RN, Faculty 701-367-6408 (office); mary.rivard@und.edu 
 





UNIVERSITY OF NORTH DAKOTA 
Institutional Review Board 
Informed Consent Statement 
 
Title of Project: Accurate Documentation of Smoking History through a 
Clinical Workflow Improvement Project 
 
Principal Investigator: Heidi Bender, 701-340-0754 (cell); 701-857-5741 (office) 
 
Advisor: Dr. Mary Jane Rivard, College of Nursing and Professional 
Disciplines, 430 Oxford St. Stop 9025, Grand Forks, ND 58202. 
Phone: 701-367-6408. 
 
Purpose of the Study: 
The purpose of this research study is to improve the smoking history intake process to have the 
appropriate information to accurately identify candidates for lung cancer screening. 
 
Procedures to be followed: 
The investigator is developing a clinical workflow improvement project to improve identification 
of patients at high-risk for lung cancer. You will be asked to complete pre- and post-intervention 
surveys. 
 
Risks:   
There are no risks in participating in this research beyond those experienced in everyday life.  
 
Benefits: 
You will not benefit personally from being in this study. However, we hope that, in the future, 
other people might benefit from this study because improved accuracy of smoking history 
documentation will likely lead to an improved effort and ability to identify patients who are at 
risk for lung cancer. This identification may allow that patient access to a life-saving cancer 
screening examination. Patients who are screened for lung cancer with low-dose computerized 
tomography have a 20% reduction in death rate. 
 
Duration: 
It will take approximately 15 minutes to complete each survey. 
 
Statement of Confidentiality: 
Surveys will be linked by an anonymous number only. When the surveys are distributed, you 
will create a unique, de-personalized identifier such as an ID number or code to place on the 
survey. You will need to remember and provide this unique identifier the next time you complete 
the survey. The data recorded will be stored for a period of three years in a locked cabinet within 
the principal investigators workplace. Data entered within an electronic source will be accessed 
with the data password protected. 
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Right to Ask Questions: 
The researcher conducting this study is Heidi Bender.  You may ask any questions you have 
now.  If you later have questions, concerns, or complaints about the research please contact Heidi 
Bender, 701-857-5741 (office), 701-340-0754 (cell); heidi.bender@ndus.edu; 
heidi.bender@trinityhealth.org. The faculty advisor is Dr. Mary Jo Rivard and she can be 
contacted at 701-367-6408. 
 
If you have questions regarding your rights as a research subject, you may contact The 
University of North Dakota Institutional Review Board at (701) 777-4279.  You may also call 
this number with problems, complaints, or concerns about the research.  Please call this number 
if you cannot reach research staff, or you wish to talk with someone who is an informed 
individual who is independent of the research team. 
 
General information about being a research subject can be found on the Institutional Review 




You will not receive compensation for your participation. 
 
Voluntary Participation: 
You do not have to participate in this research.  You can stop your participation at any time.  
You may refuse to participate or choose to discontinue participation at any time without losing 
any benefits to which you are otherwise entitled. There will be not any repercussions within your 
place of employment if you choose not to participate. 
 
You do not have to answer any questions you do not want to answer. 
 
You must be 18 years of age older to consent to participate in this research study. 
 
Completion and return of the surveys implies that you have read the information in this form and 
consent to participate in the research. 
 





















Pre-Intervention Survey: Perception of Knowledge, Attitudes, and Practices (KAP) 
 
Title of the Study: Accurate Documentation of Smoking History through a Clinical 
Workflow Improvement Project 
  
In the U.S., more people die from lung cancer than breast, colon, and prostate cancer combined. 
Lung cancer screening has been available in the U.S. since 2015. Identifying candidates for lung 
cancer screening, within the electronic medical record is difficult. To assess the knowledge, 
attitudes and procedures of smoking history intake, some information is required from you. Your 
response will significantly contribute this workflow improvement project. Your participation will 
be kept confidential. The survey does not ask for any information that will identify who 
submitted the responses to and no individual identifying information will be collected. Therefore, 
your responses are recorded anonymously. If this research is published, no information that can 
identify you will be included since your name is in no way linked to your responses. There are 


































Age: 18-25   Gender: Male  Years as healthcare provider:  <1  
 26-30     Female         2-5 
 31-40                    6-10 
 41-50                   11-15 
 51-60                   16-20 
 61-70                  21-30  




Highest educational level: High-school diploma  Employment status:   
    GED                 Full-time 
    Associate’s degree               Part-time 
    Bachelor’s degree       Casual 
    Master’s degree 
    Doctoral degree   





Current work location: Internal Medicine 
    Family Medicine 
    Pulmonary Medicine  




Do you smoke cigarettes: Yes  Former smoker? Yes 




















1. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree, I have 










1 2 3 4 5 6 
 
 
2. On a scale of 1-6 with 1 being definitely not confident and 6 being definitely confident; I am 














1 2 3 4 5 6 
 
 
3. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; this in-service 










1 2 3 4 5 6 
 
 
4. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; I plan to 
implement what I have learned from this in-service regarding the importance of accurate 


























5. What smoking history data points are necessary to gather to accurately identify lung cancer 
screening candidates? 
a. Age, is the patient a current or former smoker, what year or age did the patient 
begin smoking, what year or age did the patient stop smoking, how many packs 
per day did the patient smoke? 
b. Is the patient a current or former smoker, what year or age did the patient begin 
smoking, what year or age did the patient stop smoking, how many packs per day 
did the patient smoke? 
c. Gender, is the patient a current or former smoker, what year or age did the patient 
begin smoking, what year or age did the patient stop smoking, how many packs 
per day did the patient smoke? 
d. Is the patient a current or former smoker and how many packs per day did the 
patient smoke? 
 
6. What smoking history information is necessary to obtain to calculate a pack-year smoking 
history? 
a. Year started smoking, numbers of years smoked, former or current smoker. 
b. Number of years smoked and number of packs per day. 
c. Year quit smoking, numbers of years smoked. 





7. On a scale of 1-6; with 1 being extremely unimportant and 6 being extremely important; how 










1 2 3 4 5 6 
 
 
8. On a scale of 1-6; with 1 being extremely unimportant and 6 being extremely important; 
generally speaking, how important is the identification of patients at high-risk for lung 
















ACCURATE DOCUMENTATION OF SMOKING HISTORY 56 
 
 
KAP Survey           
 
9. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; generally 
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10. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; the provider I 
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11. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; obtaining an 















12. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; how I obtain 




























13. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; I believe that 
accurately documenting an appropriate smoking history, improves patients’ access to 
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1 2 3 4 5 6 
 
 
15. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; I am expected 
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16. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; my patients 










1 2 3 4 5 6 
 
 
17. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; it is important 
for me to document an accurate smoking history, in order for the provider I work with 





















Post-Intervention Survey: Perception of Knowledge, Attitudes, and Practices (KAP) 
 
Title of the Study: Accurate Documentation of Smoking History through a Clinical 
Workflow Improvement Project 
  
In the U.S., more people die from lung cancer than breast, colon, and prostate cancer combined. 
Lung cancer screening has been available in the U.S. since 2015. Identifying candidates for lung 
cancer screening, within the electronic medical record is difficult. To assess the knowledge, 
attitudes and procedures of smoking history intake, some information is required from you. Your 
response will significantly contribute this workflow improvement project. Your participation will 
be kept confidential. The survey does not ask for any information that will identify who 
submitted the responses to and no individual identifying information will be collected. Therefore, 
your responses are recorded anonymously. If this research is published, no information that can 
identify you will be included since your name is in no way linked to your responses. There are 



































1. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree, I have 










1 2 3 4 5 6 
 
 
2. On a scale of 1-6 with 1 being definitely not confident and 6 being definitely confident; I am 














1 2 3 4 5 6 
 
 
3. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; this in-service 










1 2 3 4 5 6 
 
 
4. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; I plan to 
implement what I have learned from this in-service regarding the importance of accurate 


























5. What smoking history data points are necessary to gather to accurately identify lung cancer 
screening candidates? 
a. Age, is the patient a current or former smoker, what year or age did the patient 
begin smoking, what year or age did the patient stop smoking, how many packs 
per day did the patient smoke? 
b. Is the patient a current or former smoker, what year or age did the patient begin 
smoking, what year or age did the patient stop smoking, how many packs per day 
did the patient smoke? 
c. Gender, is the patient a current or former smoker, what year or age did the patient 
begin smoking, what year or age did the patient stop smoking, how many packs 
per day did the patient smoke? 
d. Is the patient a current or former smoker and how many packs per day did the 
patient smoke? 
 
6. What smoking history information is necessary to obtain to calculate a pack-year smoking 
history? 
a. Year started smoking, numbers of years smoked, former or current smoker. 
b. Number of years smoked and number of packs per day. 
c. Year quit smoking, numbers of years smoked. 




7. On a scale of 1-6; with 1 being extremely unimportant and 6 being extremely important; how 
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8. On a scale of 1-6; with 1 being extremely unimportant and 6 being extremely important; 
generally speaking, how important is the identification of patients at high-risk for lung 






















9. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; generally 
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10. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; the provider I 
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11. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; obtaining an 















12. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; how I obtain 





























13. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; I believe that 
accurately documenting an appropriate smoking history, improves patients’ access to 
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1 2 3 4 5 6 
 
 
15. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; I am expected 










1 2 3 4 5 6 
 
 
16. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; my patients 
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17. On a scale of 1-6; with 1 being strongly disagree and 6 being strongly agree; it is important 
for me to document an accurate smoking history, in order for the provider I work with 
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Appendix G 
BUSINESS ASSOCIATE AGREEMENT 
 




 xxxxxxxxxx (“Covered Entity”) 
 




A. Covered Entity and Business Associate have entered into one or more agreements 
(collectively, the “Agreement”) in which Business Associate agreed to provide 
certain services to Covered Entity, which services may involve Business Associate’s 
receipt, use, disclosure or creation of Protected Health Information on behalf of 
Covered Entity. 
B. The parties desire to enter into this Business Associate Agreement (the “BAA”) to 
reflect their understandings and obligations with regard to Protected Health 
Information. 
 
NOW, THEREFORE, in consideration of the mutual covenants and promises made by and 







 1.1) Catch-All Definition.  Terms used, but not otherwise defined, in this BAA shall 
have the same meaning as those terms in the Privacy Rule and Security Rule. 
 
 1.2) Specific Definitions. 
 
(a) Breach.  “Breach” shall have the same meaning as the term “breach” in 45 
CFR 164.402. 
 
(b) Designated Record Set.  “Designated Record Set” shall have the same 
meaning as the term “designated record set” in 45 CFR 164.501. 
 
(c) Electronic Protected Health Information.  “Electronic Protected Health 
Information” shall mean individually identifiable health information that is transmitted in 
or maintained by electronic media. 
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(d) Individual.  “Individual” shall have the same meaning as the term  
“individual” in 45 CFR 160.103 and shall include a person who qualifies as a personal 
representative in accordance with 45 CFR 164.502(g). 
 
(e) Privacy Rule.  “Privacy Rule” shall mean the Standards for Privacy of 
Individually Identifiable Health Information at 45 CFR part 160 and part 164, subparts A, 
D and E. 
 
(f) Protected Health Information.  “Protected Health Information” shall have 
the same meaning as the term “protected health information” in 45 CFR 160.103, limited 
to the information created or received by Business Associate from or on behalf of 
Covered Entity. 
 
(g)  Required By Law.  “Required By Law” shall have the same meaning as 
the term “required by law” in 45 CFR 164.103. 
 
(h)  Secretary.  “Secretary” shall mean the Secretary of the Department of 
Health and Human Services or his designee. 
 
(i) Security Incident.  “Security Incident” shall mean the attempted or 
successful unauthorized access, use, disclosure, modification, or destruction of 
information or interference with system operations in an information system. 
 
(j) Security Rule.  “Security Rule” shall mean the Security Standards at 45 
CFR Parts 160, 162 and 164. 
 
ARTICLE 2. 
OBLIGATIONS AND ACTIVITIES OF BUSINESS ASSOCIATE 
 
 2.1) Regulatory Compliance.  Business Associate agrees that it shall comply with the 
provisions of the Privacy Rule and Security Rule to the extent such regulations apply directly to 
Business Associate. 
 
 2.2)  General.  Business Associate agrees not to use or disclose Protected Health 
Information other than as permitted or required by this BAA or as Required By Law. 
 
 2.3)  Safeguards.  Business Associate agrees to implement and use appropriate 
safeguards to prevent use or disclosure of the Protected Health Information other than as 
provided for by this BAA.  Business Associate agrees to implement administrative, physical and 
technical safeguards that reasonably and appropriately protect the confidentiality, integrity and 
availability of the Electronic Protected Health Information that it creates, receives, maintains or 
transmits on behalf of Covered Entity. 
 
 2.4)  Mitigation.  Business Associate agrees to mitigate, to the extent practicable, any 
harmful effect that is known to Business Associate of a use or disclosure of Protected Health 
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Information by Business Associate in violation of the requirements of this BAA including any 
Breach. 
 
 2.5)  Reporting Disclosures and Breaches.  Business Associate agrees to report to 
Covered Entity: 
 
(a) any improper use or disclosure of the Protected Health Information within 
10 days of discovery of such improper use or disclosure; 
 
(b) any Security Incident of which it becomes aware, within 5 days of 
discovery; and 
 
(c) any Breach or probable Breach, within one day of becoming aware of the 
Breach or probable Breach.  Business Associate may make the initial report orally, but 
shall provide a full written report to Covered Entity within five days of providing oral 
notice.  Each report (oral or written) shall include, to the extent available at the time of 
the report, a description of the breach, the Protected Health Information disclosed 
(including names and contact information), and a description of any remedial action(s) 
taken by Business Associate. 
 
 2.6)  Agents and Subcontractors.  Business Associate agrees to ensure that any agent, 
including a subcontractor, to whom it provides Protected Health Information or Electronic 
Protected Health Information received from, or created or received by Business Associate on 
behalf of Covered Entity agrees to the same restrictions and conditions that apply through this 
BAA to Business Associate with respect to such information.  Business Associate agrees to 
ensure that any such agent or subcontractor to whom it provides Electronic Protected Health 
Information agrees to implement reasonable and appropriate safeguards to protect such 
information. 
 
 2.7)  Access to Protected Health Information.  In the event Business Associate 
maintains Protected Health Information in a Designated Record Set, Business Associate agrees 
to provide access, at the request of Covered Entity, and in the time and manner determined by 
Covered Entity, to Protected Health Information in a Designated Record Set to Covered Entity 
or, as directed by Covered Entity, to an Individual in order to meet the requirements under 45 
CFR 164.524. 
 
 2.8)  Amendment of Protected Health Information.  In the event Business Associate 
maintains Protected Health Information in a Designated Record Set, Business Associate agrees 
to make any amendment(s) to Protected Health Information in a Designated Record Set that the 
Covered Entity directs or agrees to pursuant to 45 CFR 164.526 at the request of Covered Entity 
or an Individual, and in the time and manner determined by Covered Entity. 
 
 2.9)  Access and Inspection.  Business Associate agrees to make internal practices, 
books, and records, including policies and procedures and Protected Health Information, relating 
to the use and disclosure of Protected Health Information received from, or created or received 
by Business Associate on behalf of, Covered Entity available to Covered Entity, or to the 
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Secretary, in a time and manner designated by Covered Entity or the Secretary, for purposes of 
the Secretary determining Covered Entity’s compliance with the Privacy Rule. 
 
 2.10)  Accounting of Disclosures.  Business Associate agrees to document such 
disclosures of Protected Health Information and information related to such disclosures as would 
be required for Covered Entity to respond to a request by an Individual for an accounting of 
disclosures of Protected Health Information in accordance with 45 CFR 164.528.  Business 
Associate agrees to provide to Covered Entity or an Individual, in a time and manner designated 
by Covered Entity, the information collected to permit Covered Entity to respond to a request by 
an Individual for an accounting of disclosures of Protected Health Information in accordance 
with 45 CFR 164.528. 
 
ARTICLE 3. 
PERMITTED USES AND DISCLOSURES BY BUSINESS ASSOCIATE 
 
 3.1)  General Use and Disclosure.  Except as otherwise limited in this BAA, Business 
Associate may use or disclose Protected Health Information to perform functions, activities, or 
services for, or on behalf of, Covered Entity as specified in the Agreement, provided that such 
use or disclosure would not violate the Privacy Rule if done by Covered Entity or the minimum 
necessary policies and procedures of Covered Entity. 
 
 3.2)  Use for Business Purposes.  Except as otherwise limited in this BAA, Business 
Associate may use Protected Health Information for the proper management and administration 
of Business Associate or to carry out the legal responsibilities of Business Associate. 
 
 3.3)  Disclosure for Business Purposes.  Except as otherwise limited in this BAA, 
Business Associate may disclose Protected Health Information for the proper management and 
administration of Business Associate, provided that such disclosures are (a) Required By Law; or 
(b) Business Associate obtains reasonable assurances, prior to disclosure, from the person to 
whom the information will be disclosed that it will remain confidential and be used or further 
disclosed only as Required By Law or for the purpose for which it was disclosed to the person, 
and the person notifies the Business Associate of any instances of which it is aware in which the 
confidentiality of the information has been breached. 
 
 3.4)  Data Aggregation.  Except as otherwise limited in this BAA, Business Associate 
may use Protected Health Information to provide Data Aggregation services to Covered Entity as 
permitted by 45 CFR 164.504(e)(2)(i)(B) and if so requested by Covered Entity. 
 
ARTICLE 4. 
OBLIGATIONS OF COVERED ENTITY 
 
 4.1)  Notification to Business Associate.  Covered Entity shall notify Business 
Associate of:  (i) any limitation(s) in its notice of privacy practices in accordance with 45 CFR 
164.520, to the extent that such limitation may affect Business Associate’s use or disclosure of 
Protected Health Information; (ii) any changes in, or revocation of, permission by Individual to 
use or disclose Protected Health Information, to the extent that such changes may affect Business 
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Associate’s use or disclosure of Protected Health Information; and (iii) any restriction to the use 
or disclosure of Protected Health Information that Covered Entity has agreed to in accordance 
with 45 CFR 164.522, to the extent that such restriction may affect Business Associate’s use or 
disclosure of Protected Health Information. 
 
 4.2)  Requests.  Covered Entity shall not request Business Associate to use or disclose 
Protected Health Information in any manner that would not be permissible under the Privacy 
Rule if done by Covered Entity. 
 
ARTICLE 5. 
TERM AND TERMINATION 
 
 5.1)  Term.  This BAA shall be effective as of the Effective Date, and shall terminate 
when all of the Protected Health Information provided by Covered Entity to Business Associate, 
or created or received by Business Associate on behalf of Covered Entity, is destroyed or 
returned to Covered Entity, or, if it is infeasible to return or destroy Protected Health 
Information, protections are extended to such information, in accordance with the termination 
provisions in this Article 5. 
 
 5.2)  Termination for Cause.  Upon Covered Entity’s knowledge of a material breach 
by Business Associate, Covered Entity shall either: 
 
(a)  Provide an opportunity for Business Associate to cure the breach or end 
the violation and terminate the Agreement if Business Associate does not cure the breach 
or end the violation within the time specified by Covered Entity;   
 
(b) Immediately terminate the Agreement if Business Associate has breached 
a material term of this BAA and cure is not possible; or 
 
(c)  If neither termination nor cure are feasible, report the violation to the 
Secretary. 
 
 5.3)  Effect of Termination. 
 
(a)  Except as provided in paragraph (b) of this section, upon termination of 
the Agreement, for any reason, Business Associate shall return or destroy all Protected 
Health Information received from Covered Entity, or created or received by Business 
Associate on behalf of Covered Entity.  This provision shall apply to Protected Health 
Information that is in the possession of subcontractors or agents of Business Associate.  
Business Associate shall retain no copies of the Protected Health Information. 
 
(b) In the event that Business Associate determines that returning or 
destroying the Protected Health Information is infeasible, Business Associate shall 
provide to Covered Entity notification of the conditions that make return or destruction 
infeasible.  Upon the mutual agreement of the parties that return or destruction of 
Protected Health Information is infeasible, Business Associate shall extend the 
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protections of this BAA to such Protected Health Information and limit further uses and 
disclosures of such Protected Health Information to those purposes that make the return 




INDEMNIFICATION; INJUNCTIVE RELIEF 
 
 6.1) Indemnification.  Business Associate agrees to indemnify, defend and hold 
harmless Covered Entity and its directors, officers, agents, shareholders and employees from and 
against any and all claims, demands, losses, expenses, costs (including reasonable attorneys’ 
fees), damages and causes of action arising from or relating to Business Associate’s breach of 
this BAA.  In the event of a Breach by Business Associate, its agents, employees, or 
subcontractors, Business Associate will reimburse and indemnify Covered Entity’s expenses and 
costs, including attorney’s fees, that are reasonably incurred due to the Breach, including costs 
associated with the notification of Individuals and the media, as well as credit monitoring and 
other mitigating actions if determined necessary by Covered Entity. 
 
 6.2) Injunctive Relief.  The parties acknowledge that the remedy at law for any breach 
of the terms of this BAA are inadequate and that the damages resulting from such breach are not 
readily susceptible to being measured in monetary terms.  Accordingly, in the event of a breach 
or threatened breach by Business Associate or any of its subcontractors of the terms of this BAA, 
Covered Entity shall be entitled to immediate injunctive relief and may obtain a temporary order 





 7.1)  Regulatory References.  A reference in this BAA to a section in the Privacy Rule 
or Security Rule means the section as in effect or as amended. 
 
 7.2)  Amendment.  The Parties agree to take such action as is necessary to amend this 
BAA from time to time as is necessary for Covered Entity to comply with the requirements of 
the Privacy Rule and Security Rule.   
 
 7.3)  Survival.  Sections 5.3, 6.1 and 6.2 of this BAA shall survive the termination of 
the Agreement.  
 
 7.4)  Interpretation.  Any ambiguity in this BAA shall be resolved to permit Covered 
Entity to comply with the Privacy Rule or Security Rule. 
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IN WITNESS WHEREOF, the parties hereto have executed this BAA in the manner 







     By: On-file at project organization   






     By: HEIDI BENDER    
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